GR mutations leading to glucocorticoid insensitivity can affect glucocorticoid production through a dysregulation of the feedback loop (Fig. 1A) leading to a large spectrum of clinical phenotypes as adrenal hyperplasia and hypertension. This evidence concerns the gene NR3C1 and hypertensive disorder.